Medtech

 

Goldman Sachs raises $650m for life sciences

Global investment banking firm Goldman Sachs has closed one of the largest first-time private life sciences growth funds. Its West Street Life Sciences I raised "$650 million in equity commitments from a global, diverse group of institutional, strategic and high net worth investors and meaningful commitment from Goldman Sachs employees" according to the bank.

Gilde Healthcare acquires stake in Swiss Dental Solutions

Capital investor Gilde Healthcare acquires a majority stake in Swiss Dental Solutions (SDS) through its private equity fund. SDS aims to accelerate its growth in both Europe and the US and become a world leader in the emerging market of ceramic dental implants.

New AI act could stifle EU innovation – but benefit the UK

After 38 hours of deliberation, a long-awaited deal has finally been reached in Brussels. HBI speaks to three market experts to understand what the AI Act - the comprehensive European framework for AI innovation and regulation - could mean for the future of healthcare in Europe.

Workforce woes beckon in a winter of discontent

Winter is coming, and for the health care sector the end of the year could see a weary workforce and soaring costs push some groups to breaking point. HBI speaks to a selection of operators, analysts and advisers to understand how groups are planning for the potentially difficult months ahead.

See the Global Top 50 by Market Cap

Who are the Global Top 50 Health Care Service Companies by market cap and what does this tell us about the industry? What is striking is how very few of the top 50 are now EMEA companies - just 13, and of those only four are headquartered in Europe, rather than the Middle East or South Africa. 

Interview: Dr. Nadine Hachach-Haram, CEO and Founder, Proximie

HBI catches up with Dr. Nadine Hachach-Haram, the CEO and founder of global health technology platform Proximie to hear about how MedTech can improve surgical education and performance, address variations in quality of care, and bring the operating theatre into the 21st century.

HBI 2023 Panel: This time it’s personal: rethinking patient pathways

When we talk about personalised medicine, we often hear about the therapy component, but less so about the service element of care. In an HBI 2023 panel entitled ‘This time it's personal: rethinking patient pathways’ speakers argued that's exactly where personalisation should be occurring.

75 years on: is the future of the NHS private?

The UK NHS was once globally revered, but cracks are showing as it marks seventy-five years and a question mark hangs over its future. HBI asks half a dozen experts what role for-profits have in its future - and whether it will it last another 75 years.

HBI 2023: AI and Big Data – cutting diagnosis to treatment times

AI and big data are primed to improve clinical outcomes and standards for radiologists as well as the health care sector as a whole, but how far along the journey to automated care delivery are we? In an HBI 2023 panel discussion ‘AI and Big Data: Outcomes and Automation,’ panellists explored how automation could speed up diagnosis to treatment from 2 weeks to 15 minutes.

HBI 2023: The shape of things to come

In the future health care will be much more consumer-centric, personalised and outpatient-heavy. Speakers on a panel at HBI 2023 entitled ‘The shape of things to come’ explained how digitisation, data and new types of medtech are already beginning to move things in this direction.

Find Us